Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$110.81 /

+1.78 (+1.63%)

, ABC

AmerisourceBergen

$121.16 /

+0.69 (+0.57%)

04:55
04/22/21
04/22
04:55
04/22/21
04:55

American Academy of Neurology to hold a virtual meeting

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ABBV

AbbVie

$110.81 /

+1.78 (+1.63%)

ABC

AmerisourceBergen

$121.16 /

+0.69 (+0.57%)

ABT

Abbott

$122.61 /

+2.62 (+2.18%)

ACAD

Acadia Pharmaceuticals

$21.46 /

+0.67 (+3.22%)

ALNY

Alnylam

$137.67 /

+2 (+1.47%)

BIIB

Biogen

$269.13 /

-3.84 (-1.41%)

BMY

Bristol-Myers

$66.32 /

+0.265 (+0.40%)

BHVN

Biohaven Pharmaceutical

$75.13 /

+1.5 (+2.04%)

CPRX

Catalyst Pharmaceuticals

$4.52 /

+0.13 (+2.96%)

DGX

Quest Diagnostics

$130.08 /

+0.79 (+0.61%)

DNA

Ginkgo Bioworks

$94.97 /

+ (+0.00%)

HZNP

Horizon Therapeutics

$93.52 /

+2.45 (+2.69%)

LIVN

LivaNova

$83.05 /

+1.63 (+2.00%)

LLY

Eli Lilly

$191.00 /

+0.45 (+0.24%)

MDT

Medtronic

$130.19 /

+1.9 (+1.48%)

NVS

Novartis

$88.67 /

+0.84 (+0.96%)

NVTA

Invitae

$36.05 /

+1.795 (+5.24%)

PFE

Pfizer

$39.53 /

+0.5 (+1.28%)

PTCT

PTC Therapeutics

$45.78 /

-0.545 (-1.18%)

RETA

Reata Pharmaceuticals

$90.75 /

+1.17 (+1.31%)

SNY

Sanofi

$52.43 /

+0.44 (+0.85%)

SUPN

Supernus

$31.37 /

+0.61 (+1.98%)

TAK

Takeda Pharmaceutical

$16.93 /

+0.095 (+0.56%)

TEVA

Teva

$10.25 /

+0.135 (+1.33%)

TGTX

TG Therapeutics

$40.61 /

+0.64 (+1.60%)

ZGNX

Zogenix

$18.95 /

+0.09 (+0.48%)

AVDL

Avadel Pharmaceuticals

$8.46 /

+0.265 (+3.24%)

JNJ

Johnson & Johnson

$166.61 /

+0.16 (+0.10%)

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 23

    Apr

  • 23

    Apr

  • 27

    Apr

  • 28

    Apr

  • 28

    Apr

  • 28

    Apr

  • 29

    Apr

  • 29

    Apr

  • 29

    Apr

  • 30

    Apr

  • 03

    May

  • 04

    May

  • 04

    May

  • 04

    May

  • 04

    May

  • 05

    May

  • 05

    May

  • 05

    May

  • 06

    May

  • 07

    May

  • 18

    May

  • 18

    May

  • 20

    May

  • 21

    May

  • 24

    May

  • 25

    May

  • 27

    May

  • 30

    May

  • 02

    Jun

  • 07

    Jun

  • 15

    Jun

  • 21

    Jul

  • 15

    Oct

  • 29

    Dec

  • 28

    Jan

  • 29

    Apr

  • 15

    May

  • 07

    Aug

  • 02

    Dec

  • 15

    Dec

  • 22

    Jan

  • 16

    Mar

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating
04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$122.61 /

+2.62 (+2.18%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$21.46 /

+0.67 (+3.22%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$137.67 /

+2 (+1.47%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$269.13 /

-3.84 (-1.41%)

04/19/21 Jefferies
Biogen 'may have best risk/reward among large caps' in 2021-23, says Jefferies
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

04/21/21 Citi
Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
BHVN Biohaven Pharmaceutical
$75.13 /

+1.5 (+2.04%)

04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.52 /

+0.13 (+2.96%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Ginkgo Bioworks
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$83.05 /

+1.63 (+2.00%)

04/19/21 Piper Sandler
LivaNova HF enrollment milestone a key step toward approval, says Piper Sandler
04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$130.19 /

+1.9 (+1.48%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.67 /

+0.84 (+0.96%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
NVTA Invitae
$36.05 /

+1.795 (+5.24%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$39.53 /

+0.5 (+1.28%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
PTCT PTC Therapeutics
$45.78 /

-0.545 (-1.18%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$90.75 /

+1.17 (+1.31%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$52.43 /

+0.44 (+0.85%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$31.37 /

+0.61 (+1.98%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.25 /

+0.135 (+1.33%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.46 /

+0.265 (+3.24%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs

TODAY'S FREE FLY STORIES

Hot Stocks
Cathie Wood's ARK Investment bought 156.5K shares of KE Holdings on Monday  06:44
06/15/21
06/15
06:44
06/15/21
06:44
BEKE

KE Holdings

$47.55 /

-1.065 (-2.19%)

 
ShowHide Related Items >><<
BEKE KE Holdings
$47.55 /

-1.065 (-2.19%)

BEKE KE Holdings
$47.55 /

-1.065 (-2.19%)

05/20/21 86 Research
KE Holdings upgraded to Hold from Sell at 86 Research
04/23/21 China Renaissance
KE Holdings upgraded to Buy from Hold at China Renaissance
04/07/21 Credit Suisse
KE Holdings initiated with an Outperform at Credit Suisse
03/18/21 BofA
KE Holdings upgraded to Buy from Neutral at BofA
BEKE KE Holdings
$47.55 /

-1.065 (-2.19%)

  • 19
    Nov
  • 13
    Aug
BEKE KE Holdings
$47.55 /

-1.065 (-2.19%)

Recommendations
Old Dominion named short-term investment at Deutsche Bank » 06:44
06/15/21
06/15
06:44
06/15/21
06:44
ODFL

Old Dominion

$250.07 /

-0.97 (-0.39%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ODFL Old Dominion
$250.07 /

-0.97 (-0.39%)

ODFL Old Dominion
$250.07 /

-0.97 (-0.39%)

05/28/21 KeyBanc
Old Dominion price target raised to $280 from $270 at KeyBanc
04/23/21 Argus
Old Dominion price target raised to $285 from $230 at Argus
04/23/21 Deutsche Bank
Old Dominion price target raised to $250 from $224 at Deutsche Bank
04/07/21 Stephens
Old Dominion price target raised to $280 from $240 at Stephens
ODFL Old Dominion
$250.07 /

-0.97 (-0.39%)

ODFL Old Dominion
$250.07 /

-0.97 (-0.39%)

Downgrade
CCC downgraded to Hold from Buy at HSBC » 06:42
06/15/21
06/15
06:42
06/15/21
06:42
CCCTY

CCC

/

+

HSBC analyst Bulent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Crane upgraded to Buy from Neutral at DA Davidson » 06:37
06/15/21
06/15
06:37
06/15/21
06:37
CR

Crane

$90.81 /

-1.26 (-1.37%)

DA Davidson analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CR Crane
$90.81 /

-1.26 (-1.37%)

CR Crane
$90.81 /

-1.26 (-1.37%)

05/05/21 DA Davidson
Crane price target raised to $105 from $85 at DA Davidson
03/08/21 Canaccord
Crane price target raised to $100 from $96 at Canaccord
01/07/21 Vertical Research
Crane upgraded to Buy with $97 price target at Vertical Research
01/07/21 DA Davidson
Crane cut to Neutral at DA Davidson on valuation
CR Crane
$90.81 /

-1.26 (-1.37%)

CR Crane
$90.81 /

-1.26 (-1.37%)

CR Crane
$90.81 /

-1.26 (-1.37%)

Hot Stocks
Solid Power to become public through Decarbonization Plus Acquisition III merger » 06:37
06/15/21
06/15
06:37
06/15/21
06:37
DCRC

Decarbonization Plus Acquisition III

$12.03 /

-0.36 (-2.91%)

, SLDP

Solid Power

/

+

Solid Power and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DCRC Decarbonization Plus Acquisition III
$12.03 /

-0.36 (-2.91%)

DCRC Decarbonization Plus Acquisition III
$12.03 /

-0.36 (-2.91%)

Initiation
Invitae initiated with an Outperform at Raymond James » 06:34
06/15/21
06/15
06:34
06/15/21
06:34
NVTA

Invitae

$31.50 /

+0.31 (+0.99%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVTA Invitae
$31.50 /

+0.31 (+0.99%)

NVTA Invitae
$31.50 /

+0.31 (+0.99%)

06/03/21 Goldman Sachs
Invitae initiated with a Neutral at Goldman Sachs
05/25/21 Wells Fargo
Invitae initiated with an Equal Weight at Wells Fargo
04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
NVTA Invitae
$31.50 /

+0.31 (+0.99%)

  • 22
    Jan
NVTA Invitae
$31.50 /

+0.31 (+0.99%)

Hot Stocks
Canadian National, Kansas City Southern jointly file documents with STB » 06:34
06/15/21
06/15
06:34
06/15/21
06:34
CNI

Canadian National

$111.05 /

+0.72 (+0.65%)

, KSU

Kansas City Southern

$292.28 /

-1.645 (-0.56%)

CN (CNI) and Kansas City…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNI Canadian National
$111.05 /

+0.72 (+0.65%)

KSU Kansas City Southern
$292.28 /

-1.645 (-0.56%)

CNI Canadian National
$111.05 /

+0.72 (+0.65%)

05/28/21 UBS
Canadian National upgraded to Buy from Neutral at UBS
05/28/21 Barclays
Kansas City Southern downgraded to Underweight from Equal Weight at Barclays
05/27/21 Scotiabank
Canadian Pacific price target raised to C$108 from C$96 at Scotiabank
05/27/21 Scotiabank
Canadian National upgraded to Outperform at Scotiabank after 12% pullback
KSU Kansas City Southern
$292.28 /

-1.645 (-0.56%)

05/28/21 UBS
Canadian National upgraded to Buy from Neutral at UBS
05/28/21 Barclays
Kansas City Southern downgraded to Underweight from Equal Weight at Barclays
05/27/21 Scotiabank
Canadian Pacific price target raised to C$108 from C$96 at Scotiabank
05/27/21 Scotiabank
Canadian National upgraded to Outperform at Scotiabank after 12% pullback
CNI Canadian National
$111.05 /

+0.72 (+0.65%)

KSU Kansas City Southern
$292.28 /

-1.645 (-0.56%)

CNI Canadian National
$111.05 /

+0.72 (+0.65%)

KSU Kansas City Southern
$292.28 /

-1.645 (-0.56%)

CNI Canadian National
$111.05 /

+0.72 (+0.65%)

KSU Kansas City Southern
$292.28 /

-1.645 (-0.56%)

CNI Canadian National
$111.05 /

+0.72 (+0.65%)

KSU Kansas City Southern
$292.28 /

-1.645 (-0.56%)

Initiation
Lument Finance Trust initiated with an Outperform at Raymond James » 06:33
06/15/21
06/15
06:33
06/15/21
06:33
LFT

Lument Finance Trust

$4.21 /

+0.155 (+3.82%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LFT Lument Finance Trust
$4.21 /

+0.155 (+3.82%)

02/05/21 JonesTrading
Lument Finance Trust initiated with a Buy at JonesTrading
LFT Lument Finance Trust
$4.21 /

+0.155 (+3.82%)

LFT Lument Finance Trust
$4.21 /

+0.155 (+3.82%)

Recommendations
Charles Schwab weakness yesterday a buying opportunity, says Deutsche Bank » 06:33
06/15/21
06/15
06:33
06/15/21
06:33
SCHW

Charles Schwab

$72.04 /

-1.88 (-2.54%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCHW Charles Schwab
$72.04 /

-1.88 (-2.54%)

SCHW Charles Schwab
$72.04 /

-1.88 (-2.54%)

06/10/21 Citi
Virtu, Charles Schwab selloffs on SEC comments overdone, says Citi
06/02/21 Wells Fargo
Charles Schwab price target raised to $88 from $76 at Wells Fargo
05/13/21 JPMorgan
Charles Schwab price target raised to $84 from $82 at JPMorgan
04/27/21
Fly Intel: Top five analyst upgrades
SCHW Charles Schwab
$72.04 /

-1.88 (-2.54%)

SCHW Charles Schwab
$72.04 /

-1.88 (-2.54%)

SCHW Charles Schwab
$72.04 /

-1.88 (-2.54%)

SCHW Charles Schwab
$72.04 /

-1.88 (-2.54%)

Hot Stocks
Sage Therapeutics and Biogen announce Waterfall study met primary endpoint » 06:32
06/15/21
06/15
06:32
06/15/21
06:32
SAGE

Sage Therapeutics

$72.85 /

-6.31 (-7.97%)

, BIIB

Biogen

$406.03 /

+9.57 (+2.41%)

Sage Therapeutics (SAGE)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$72.85 /

-6.31 (-7.97%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

SAGE Sage Therapeutics
$72.85 /

-6.31 (-7.97%)

05/05/21 Mizuho
Sage Therapeutics price target lowered to $77 from $81 at Mizuho
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Piper Sandler
Sage Therapeutics essential tremor data 'a win,' says Piper Sandler
04/07/21 Piper Sandler
Sage Therapeutics assumed with an Overweight at Piper Sandler
BIIB Biogen
$406.03 /

+9.57 (+2.41%)

06:20 Today Citi
Prothena price target raised to $57 from $39 at Citi
06/14/21 Truist
Biogen price target raised to $647 from $458 at Truist
06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/14/21 Goldman Sachs
Biogen price target raised to $436 from $246 at Goldman Sachs
SAGE Sage Therapeutics
$72.85 /

-6.31 (-7.97%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

Initiation
Beauty Health initiated with a Buy at Canaccord » 06:31
06/15/21
06/15
06:31
06/15/21
06:31
SKIN

Beauty Health

$17.77 /

+0.42 (+2.42%)

Canaccord analyst Kyle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SKIN Beauty Health
$17.77 /

+0.42 (+2.42%)

SKIN Beauty Health
$17.77 /

+0.42 (+2.42%)

SKIN Beauty Health
$17.77 /

+0.42 (+2.42%)

Hot Stocks
Clean Energy jumps over 8% in pre-market on WallStreetBets focus » 06:30
06/15/21
06/15
06:30
06/15/21
06:30
CLNE

Clean Energy

$11.17 /

+0.43 (+4.00%)

Shares of Clean Energy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLNE Clean Energy
$11.17 /

+0.43 (+4.00%)

CLNE Clean Energy
$11.17 /

+0.43 (+4.00%)

05/11/21 Needham
Clean Energy initiated with a Buy at Needham
05/10/21 Needham
Clean Energy initiated with a Buy at Needham
04/22/21 Credit Suisse
Clean Energy bears missing elements of Amazon deal, says Credit Suisse
04/20/21
Fly Intel: Top five analyst downgrades
CLNE Clean Energy
$11.17 /

+0.43 (+4.00%)

CLNE Clean Energy
$11.17 /

+0.43 (+4.00%)

CLNE Clean Energy
$11.17 /

+0.43 (+4.00%)

CLNE Clean Energy
$11.17 /

+0.43 (+4.00%)

Recommendations
Werner price target raised to $64 from $61 at Deutsche Bank » 06:30
06/15/21
06/15
06:30
06/15/21
06:30
WERN

Werner

$44.70 /

-0.65 (-1.43%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WERN Werner
$44.70 /

-0.65 (-1.43%)

WERN Werner
$44.70 /

-0.65 (-1.43%)

06/07/21
Fly Intel: Top five analyst downgrades
06/07/21 Goldman Sachs
Werner downgraded to Sell from Neutral at Goldman Sachs
03/26/21 Vertical Research
Werner reinstated with a Buy at Vertical Research
03/11/21 UBS
Werner downgraded to Neutral from Buy at UBS
WERN Werner
$44.70 /

-0.65 (-1.43%)

WERN Werner
$44.70 /

-0.65 (-1.43%)

Recommendations
Union Pacific price target raised to $256 from $252 at Deutsche Bank » 06:29
06/15/21
06/15
06:29
06/15/21
06:29
UNP

Union Pacific

$222.63 /

+1.37 (+0.62%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNP Union Pacific
$222.63 /

+1.37 (+0.62%)

UNP Union Pacific
$222.63 /

+1.37 (+0.62%)

05/28/21 Barclays
Union Pacific price target raised to $240 from $230 at Barclays
04/26/21 Deutsche Bank
Union Pacific price target raised to $252 from $239 at Deutsche Bank
04/23/21 RBC Capital
Union Pacific price target raised to $244 from $232 at RBC Capital
04/23/21 BMO Capital
Union Pacific price target raised to $240 from $230 at BMO Capital
UNP Union Pacific
$222.63 /

+1.37 (+0.62%)

UNP Union Pacific
$222.63 /

+1.37 (+0.62%)

UNP Union Pacific
$222.63 /

+1.37 (+0.62%)

Recommendations
CSX price target raised to $115 from $113 at Deutsche Bank » 06:29
06/15/21
06/15
06:29
06/15/21
06:29
CSX

CSX

$97.33 /

+0.12 (+0.12%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSX CSX
$97.33 /

+0.12 (+0.12%)

CSX CSX
$97.33 /

+0.12 (+0.12%)

05/14/21 Stephens
Canadian rail that loses KCS likely to pursue an Eastern rail, says Stephens
04/21/21 Deutsche Bank
CSX price target raised to $113 from $105 at Deutsche Bank
04/21/21 RBC Capital
CSX price target raised to $108 from $100 at RBC Capital
04/21/21 BMO Capital
CSX upgraded to Outperform from Market Perform at BMO Capital
CSX CSX
$97.33 /

+0.12 (+0.12%)

CSX CSX
$97.33 /

+0.12 (+0.12%)

CSX CSX
$97.33 /

+0.12 (+0.12%)

Upgrade
Olin upgraded to Buy from Neutral at UBS » 06:27
06/15/21
06/15
06:27
06/15/21
06:27
OLN

Olin

$47.93 /

-0.89 (-1.82%)

UBS upgraded Olin to Buy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OLN Olin
$47.93 /

-0.89 (-1.82%)

OLN Olin
$47.93 /

-0.89 (-1.82%)

06/14/21 Wells Fargo
Olin price target raised to $69 from $55 at Wells Fargo
06/11/21 JPMorgan
Olin price target raised to $61 from $51 at JPMorgan
06/09/21 Wolfe Research
Olin initiated with an Outperform at Wolfe Research
04/29/21 Vertical Research
Olin upgraded to Buy from Hold at Vertical Research
OLN Olin
$47.93 /

-0.89 (-1.82%)

OLN Olin
$47.93 /

-0.89 (-1.82%)

Upgrade
Finance of America upgraded to Strong Buy from Outperform at Raymond James » 06:26
06/15/21
06/15
06:26
06/15/21
06:26
FOA

Finance of America

$7.30 /

-0.64 (-8.06%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOA Finance of America
$7.30 /

-0.64 (-8.06%)

FOA Finance of America
$7.30 /

-0.64 (-8.06%)

04/23/21 Raymond James
First of America initiated with an Outperform at Raymond James
04/23/21 Raymond James
First of America initiated with an Outperform at Raymond James
FOA Finance of America
$7.30 /

-0.64 (-8.06%)

Periodicals
Express, Urban Outfitters, J. Crew open up to third-party sellers, WSJ reports » 06:26
06/15/21
06/15
06:26
06/15/21
06:26
EXPR

Express

$5.11 /

-0.185 (-3.50%)

, URBN

Urban Outfitters

$38.57 /

-0.08 (-0.21%)

Express (EXPR) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXPR Express
$5.11 /

-0.185 (-3.50%)

URBN Urban Outfitters
$38.57 /

-0.08 (-0.21%)

EXPR Express
$5.11 /

-0.185 (-3.50%)

06/04/21 B. Riley
Express price target raised to $4.50 from $3.50 at B. Riley
03/11/21 B. Riley Securities
Express price target raised to $3.50 from $1.50 at B. Riley Securities
01/15/21 B. Riley Securities
Express price target raised to $1.50 from $1 at B. Riley Securities
URBN Urban Outfitters
$38.57 /

-0.08 (-0.21%)

05/26/21
Fly Intel: Top five analyst upgrades
05/26/21 MKM Partners
Urban Outfitters price target raised to $41 from $36 at MKM Partners
05/26/21 BMO Capital
Urban Outfitters price target raised to $35 from $31 at BMO Capital
05/26/21 RBC Capital
Urban Outfitters price target raised to $40 from $34 at RBC Capital
EXPR Express
$5.11 /

-0.185 (-3.50%)

URBN Urban Outfitters
$38.57 /

-0.08 (-0.21%)

EXPR Express
$5.11 /

-0.185 (-3.50%)

EXPR Express
$5.11 /

-0.185 (-3.50%)

URBN Urban Outfitters
$38.57 /

-0.08 (-0.21%)

EXPR Express
$5.11 /

-0.185 (-3.50%)

URBN Urban Outfitters
$38.57 /

-0.08 (-0.21%)

Recommendations
Pegasystems price target raised to $165 from $150 at RBC Capital » 06:26
06/15/21
06/15
06:26
06/15/21
06:26
PEGA

Pegasystems

$134.83 /

+3.58 (+2.73%)

RBC Capital analyst Rishi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEGA Pegasystems
$134.83 /

+3.58 (+2.73%)

PEGA Pegasystems
$134.83 /

+3.58 (+2.73%)

06/10/21 RBC Capital
Pegasystems initiated with an Outperform at RBC Capital
06/04/21 Macquarie
Pegasystems price target raised to $170 from $165 at Macquarie
04/29/21 Needham
Pegasystems price target raised to $180 from $169 at Needham
04/29/21 JMP Securities
Pegasystems price target raised to $172 from $149 at JMP Securities
PEGA Pegasystems
$134.83 /

+3.58 (+2.73%)

PEGA Pegasystems
$134.83 /

+3.58 (+2.73%)

Recommendations
T. Rowe Price still expensive despite special dividend, says Citi » 06:24
06/15/21
06/15
06:24
06/15/21
06:24
TROW

T. Rowe Price

$192.69 /

-0.11 (-0.06%)

T. Rowe Price's $3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TROW T. Rowe Price
$192.69 /

-0.11 (-0.06%)

TROW T. Rowe Price
$192.69 /

-0.11 (-0.06%)

04/14/21
Fly Intel: Top five analyst downgrades
04/14/21 Wells Fargo
T. Rowe Price price target raised to $215 from $200 at Wells Fargo
04/14/21 Citi
T. Rowe Price downgraded to Sell from Neutral at Citi
03/30/21
Fly Intel: Top five analyst downgrades
TROW T. Rowe Price
$192.69 /

-0.11 (-0.06%)

TROW T. Rowe Price
$192.69 /

-0.11 (-0.06%)

TROW T. Rowe Price
$192.69 /

-0.11 (-0.06%)

Upgrade
Welltower upgraded to Strong Buy from Market Perform at Raymond James » 06:24
06/15/21
06/15
06:24
06/15/21
06:24
WELL

Welltower

$81.22 /

+1.7 (+2.14%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WELL Welltower
$81.22 /

+1.7 (+2.14%)

WELL Welltower
$81.22 /

+1.7 (+2.14%)

06/14/21 Wolfe Research
Welltower initiated with an Outperform at Wolfe Research
06/14/21
Fly Intel: Top five analyst upgrades
06/14/21 Evercore ISI
Welltower upgraded to Outperform from In Line at Evercore ISI
06/03/21 Deutsche Bank
Welltower price target raised to $80 from $76 at Deutsche Bank
WELL Welltower
$81.22 /

+1.7 (+2.14%)

WELL Welltower
$81.22 /

+1.7 (+2.14%)

Recommendations
ZoomInfo price target lowered to $60 from $64 at RBC Capital » 06:23
06/15/21
06/15
06:23
06/15/21
06:23
ZI

ZoomInfo

$46.35 /

-0.1 (-0.22%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZI ZoomInfo
$46.35 /

-0.1 (-0.22%)

ZI ZoomInfo
$46.35 /

-0.1 (-0.22%)

05/04/21 Truist
ZoomInfo price target raised to $70 from $67 at Truist
05/04/21 Deutsche Bank
ZoomInfo price target lowered to $54 from $58 at Deutsche Bank
05/04/21 Barclays
ZoomInfo price target raised to $59 from $57 at Barclays
04/22/21 Wolfe Research
ZoomInfo initiated with an Outperform at Wolfe Research
ZI ZoomInfo
$46.35 /

-0.1 (-0.22%)

  • 02
    Dec
  • 20
    Aug
ZI ZoomInfo
$46.35 /

-0.1 (-0.22%)

Upgrade
Toray Industries upgraded to Neutral from Sell at Goldman Sachs » 06:22
06/15/21
06/15
06:22
06/15/21
06:22
TRYIY

Toray Industries

$13.74 /

+0.02 (+0.15%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRYIY Toray Industries
$13.74 /

+0.02 (+0.15%)

11/25/20 Jefferies
Toray Industries upgraded to Hold from Underperform at Jefferies
07/17/20 Goldman Sachs
Toray Industries downgraded to Sell from Neutral at Goldman Sachs
06/16/20 Morgan Stanley
Toray Industries downgraded to Equal Weight from Overweight at Morgan Stanley
Hot Stocks
Cathie Wood's ARK Investment bought 21.1K shares of Unity Software on Monday  06:20
06/15/21
06/15
06:20
06/15/21
06:20
U

Unity Software

$102.29 /

+2.58 (+2.59%)

 
ShowHide Related Items >><<
U Unity Software
$102.29 /

+2.58 (+2.59%)

U Unity Software
$102.29 /

+2.58 (+2.59%)

05/14/21
Fly Intel: Top five analyst upgrades
05/14/21 Oppenheimer
Unity Software upgraded to Outperform from Perform at Oppenheimer
05/13/21 DA Davidson
Unity Software price target lowered to $150 from $175 at DA Davidson
05/12/21
Fly Intel: Top five analyst upgrades
U Unity Software
$102.29 /

+2.58 (+2.59%)

  • 08
    Feb
  • 18
    Sep
U Unity Software
$102.29 /

+2.58 (+2.59%)

U Unity Software
$102.29 /

+2.58 (+2.59%)

Recommendations
Prothena price target raised to $57 from $39 at Citi » 06:20
06/15/21
06/15
06:20
06/15/21
06:20
PRTA

Prothena

$47.67 /

+2.53 (+5.60%)

, BIIB

Biogen

$406.03 /

+9.57 (+2.41%)

Citi analyst Neena…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTA Prothena
$47.67 /

+2.53 (+5.60%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

PRTA Prothena
$47.67 /

+2.53 (+5.60%)

06/11/21 RBC Capital
Prothena price target raised to $50 from $28 at RBC Capital
06/10/21 H.C. Wainwright
Prothena price target raised to $58 from $33 at H.C. Wainwright
06/08/21 Oppenheimer
Prothena price target raised to $54 from $45 at Oppenheimer
06/08/21 Cantor Fitzgerald
Prothena price target raised to $62 from $43 at Cantor Fitzgerald
BIIB Biogen
$406.03 /

+9.57 (+2.41%)

06/14/21 Truist
Biogen price target raised to $647 from $458 at Truist
06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/14/21 Goldman Sachs
Biogen price target raised to $436 from $246 at Goldman Sachs
06/11/21
Fly Intel: Top five analyst upgrades
PRTA Prothena
$47.67 /

+2.53 (+5.60%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

  • 24
    Mar
BIIB Biogen
$406.03 /

+9.57 (+2.41%)

PRTA Prothena
$47.67 /

+2.53 (+5.60%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.